Dr. Abud Bakri

It's rough.

And plus millions of people have already used BPC 157 through research use only websites.

So I think millions is fair.

But now how do you reel that back?

Like it's already the cat's out of the bag.

So like there's no financial incentive to run the giant study.

Unless, like, we crowdfund it as, you know, peptide-curious people.

I'm on the wards of the hospital, admitting patients from the ER to the floor, to the ICU, managing very complex disease ranging from simple pneumonia to a coronary artery bypass patient.

So that whole spectrum.

What are those five?

I would say to complete the phase one, phase two on the ulcerative colitis, do that phase three trial on proving that it has benefits for ulcerative colitis.

And I don't think we'd need to use an enema.

We could probably have an encapsulated version that releases deeper into the intestines.

So fix the gut, fix the ulcer gut.

Yes.

In conjunction with that, you could do a trial on like, you know, GERD.

That's a simple condition.

A lot of people have it randomized to BPC-157 oral capsules versus pantoprazole.

Okay.

I mean, anecdotally, when I travel, I have a bottle of BPC orally.